ReHealth Estate: How Longevity Quietly Took Over the Property Market
2 years ago, I coined the term ReHealth Estate — a deliberate mashup of health and real estate — and laid out the idea in one of my books: that longevity science was about to move out of the clinic and into the walls, air, and floor plans of the places we actually live. At the time, it read as a forecast. Today, it reads as a description of what is already being built. Projects blending life-extension science with property development are now surfacing on nearly every continent, and the industry finally has the data, the capital, and even the regulation to back up what was once just a hunch. You can read more about the original concept at danamarduk.com/book5.
For the better part of ten years, longevity belonged to two places: the research lab and the clinic waiting room. Not anymore. Developers across several major markets are now constructing individual homes — and occasionally entire neighborhoods — engineered around a single promise: a longer, healthier life. Diagnostics, structured prevention programs, and health-driven architecture aren't side perks anymore. Increasingly, they're the entire reason a project gets greenlit.
This matters for a much bigger reason than any single building. An idea that used to live in supplement bottles and lab reports is migrating into the physical spaces where people spend the vast majority of their lives. That shift quietly converts a home from a passive investment into an active health tool, and it hands the longevity movement an entirely new pipeline for capital. But it also drags along a familiar headache: figuring out what's real science and what's simply dressed up to look that way.
Decoding the Price Tag
Every property in this space gets measured against one yardstick: how much extra a buyer pays for a unit stamped with a wellness, hotel, or luxury name, versus a comparable unit next door with no name attached at all. That gap turns out to be anything but consistent.
Averaged across the globe, that markup sits at roughly 30 to 33 percent, per Savills' research — but the average flattens out huge regional swings. In London, where the baseline housing stock is already top-tier, a brand barely moves the needle, adding only about 8 percent. Certain pockets of New York see the markup evaporate almost entirely, with a handful of standout unbranded towers actually outselling their branded neighbors. Move into younger, less-established markets, though, and that number jumps to 44–54 percent, because there the brand name is doing work the local market can't do on its own — guaranteeing construction quality, security, service, and future resale demand. Dubai, the most active market in this category, has seen individual projects command markups approaching 90 percent. Add a genuinely built-out health and longevity program into the mix, and the Global Wellness Institute finds it tacks on another 10 to 25 percent on top of everything else.
Here's the part worth sitting with: this markup isn't a single ingredient — it's three, stacked into one number. There's the brand itself, buying scarcity, quality assurance, and resale confidence. There's the physical structure — its airflow, water systems, natural light, and layout. And then there's the ongoing medical and concierge operation, which has to be funded and staffed every single year, not just at the ribbon-cutting. That third piece is where most buyers and investors get tripped up — it isn't a one-time cost, it's a recurring commitment, and the premium only survives as long as the lived experience actually lives up to what was advertised. Cut corners on the operational side, and the expense doesn't vanish — it just quietly eats away at the premium.
The Data Behind the Hype
What separates a legitimate ReHealth Estate development from a glorified marketing pitch comes down to evidence, and that evidence turns out to be more robust than most people assume.
The strongest research comes out of Harvard's T.H. Chan School of Public Health, via its multi-year, NIH-backed COGfx research program studying indoor air quality. Under controlled lab conditions, simply relocating people from an ordinary building into a properly ventilated, low-pollutant space nearly doubled their scores on cognitive tests. That wasn't just a lab fluke — in actual occupied buildings, residents of green-certified spaces scored about 26 percent higher on cognition, reported 30 percent fewer sick-building complaints, and slept roughly 6 percent better than people living in otherwise similar buildings. A subsequent study spanning a hundred buildings confirmed the pattern was linear — the more particulate matter and CO2 climbed, the more cognitive performance dropped in response. Ventilation and air filtration, it turns out, aren't luxury add-ons. They're functioning as direct cognitive inputs.
That effect doesn't stop at the front door, either. A review pulling together fifty-six separate studies on neighborhood design and cognitive aging found that access to green space, walkable streets, and nearby daily errands consistently correlated with sharper thinking and lower dementia risk among older adults — while proximity to heavy traffic, a reasonable stand-in for chronic air pollution exposure, tracked in the opposite direction. None of this guarantees that any specific property adds years to anyone's life. But it does hand investors something concrete to work with: air quality, natural light, greenery, and daily movement are measurable levers affecting sleep and long-term brain health — and a building genuinely engineered around those levers is delivering something real, not just a compelling narrative.
The Industry Finally Gets a Rulebook
For years, this space grew without any formal boundaries, which is exactly what allowed the marketing to sprint ahead of the substance. That changed in April 2026, when the Global Wellness Institute officially split out "longevity residences" as their own distinct category, separate from generic wellness housing. The requirements are noticeably stricter than a glossy sales brochure: an actual clinical component, health infrastructure built into the residence rather than accessible only by shuttle, structured prevention protocols like biomarker tracking, environmental design purpose-built for long-term health, and a named physician taking responsibility for medical oversight.
Regulators have started backing that framework from the outside, too. Abu Dhabi's Department of Health rolled out what it calls the world's first licensing system for Healthy Longevity Medicine Centres, with binding clinical standards active since April 2025 and its first officially licensed clinic already up and running under those rules. For an industry whose single biggest vulnerability has always been the unverifiable claim, a licensing structure is a genuinely meaningful development — the medical layer of ReHealth Estate is shifting from brochure language into something governments actually oversee.
Who's Actually Breaking Ground
Given how young this category still is, its handful of real, in-progress projects tell you more than any market forecast could.
The boldest of the bunch is SHA Residences Emirates Island, a development from Abu Dhabi-based IMKAN anchored by the SHA Wellness Clinic. Billed as the first island ever built entirely around the longevity concept, it includes 137 residences on AlJurf, the stretch of coastline between Dubai and Abu Dhabi, priced from roughly $2.5 million up to $35 million, with move-ins targeted for 2027 and Knight Frank running sales. It's the latest chapter in a lineage that started with a clinic in Spain and a residential project in Mexico, and buyers are promised ongoing access to SHA's diagnostic and longevity services.
Six Senses Residences, on Dubai Marina, takes the same underlying concept and applies it at a smaller footprint — bringing hotel-grade health infrastructure into standalone private homes rather than a full resort complex. Over in Milan, biohacking clinic The Longevity Suite teamed up with the design firm Visionnaire to bake health systems directly into a building's architecture starting at the blueprint stage, rather than retrofitting them in afterward — with expansion into Dubai, Riyadh, and Miami already planned. Meanwhile in Dubai, developer R.Evolution's Eywa project pushes the idea further than any of the others, marketing itself as "regenerative real estate" and treating the architecture itself as an active health tool rather than a bonus feature mentioned at closing. Canyon Ranch, in Austin, rounds out the list of names currently defining this space.
The size and ambition vary wildly across these five. The underlying logic doesn't: the building itself is the product, and health is the entire point of it.
Why Big Money Is Paying Attention
The growth numbers make the shift hard to ignore. Savills tracks branded residential projects climbing from 323 in 2015 to more than 900 by 2025, with the pipeline suggesting something close to 1,750 by 2032. Projects launched with no attached hotel now represent over 40 percent of new developments, up sharply from just 15 percent back in 2018 — evidence that health-centered living has become a standalone reason to build, rather than an add-on feature bolted to a resort. And the capital funding all of this is maturing right alongside it, shifting away from one-off luxury purchases and into dedicated investment funds, REIT vehicles, and family-office partnerships — typically the tipping point where a passing trend hardens into a genuine asset class.
Demographics are driving the demand. An aging population of ultra-wealthy buyers is increasingly ranking health and lifespan extension at the very top of their priority list, and wants that priority baked directly into where they live rather than treated as an occasional wellness retreat. The underlying market is massive — UBS Global Wealth Management estimates the global longevity economy at $5.3 trillion as of 2023, climbing toward $8 trillion by 2030. Sotheby's International Realty's 2026 mid-year luxury report found that longevity has become a defining factor in top-tier real estate decisions, with the firm's own marketing chief noting that wellness has graduated from being a nice-to-have amenity to becoming the organizing principle of the entire purchase.
Tracing Where the Actual Return Comes From
For anyone looking to invest, the first decision isn't which project to back — it's which layer of the industry to actually own. Public markets only offer indirect exposure, through health and wellness infrastructure REITs, which typically hold senior living facilities, medical office buildings, and lab space rather than the residential projects described here; they're liquid and pay dividends, but they sit one step removed from the category and remain sensitive to interest-rate swings. Direct exposure comes through owning individual units, developer or joint-venture equity stakes, private real estate funds, or — closest to the actual thesis — equity positions in the clinical and operational platforms themselves.
A health-focused residence generates income in two distinct ways: appreciation on the real estate itself, and a recurring service business built on wellness and clinical fees. The upfront development premium is the return everyone sees. The recurring operational income is the return that actually lasts — and it's the piece that has to be re-earned every year, without exception. Much like the more established senior-housing sector this category resembles, the payoff ultimately tracks back to the operator running the place, not the building itself.
The risks here are specific and worth naming plainly: private stakes are illiquid and locked in for the long haul, the publicly listed alternatives carry interest-rate exposure, and every position carries real execution risk, since the premium quietly evaporates wherever the clinical operation underneath it is underfunded. The project pipeline is also heavily concentrated geographically, with a disproportionate share sitting in Dubai specifically. And anywhere a genuine clinical component exists, regulatory and licensing risk comes bundled in — a burden a plain vanilla real estate asset never has to carry.
Telling the Real Deal From the Knockoffs
This is ultimately where the industry's long-term credibility gets decided. The same premium that rewards a legitimate operator also lures in developments hoping to charge the price without actually funding the program behind it — and the difference is spottable if you know what you're looking at. A weak project has a recognizable look: a slick spa rendering, one recognizable wellness-brand logo, some vague language about an "integrated philosophy," and nothing else — no named medical director, no published clinical protocol, and critically, no recurring wellness fee, arguably the single clearest tell that there's no real ongoing program being funded at all.
A legitimate ReHealth Estate project, by contrast, can produce all of the above on request: an accountable operator, infrastructure genuinely built into the residence, real physician-led clinical oversight, and an actual named person responsible for the health programming. Resale performance will sort out the pretenders from the real thing over time — branded, health-focused properties have historically retained value better through market downturns, but strictly in cases where the service actually delivered on what was promised.
Zooming Out
Step back, and the real significance here extends well beyond any individual project. ReHealth Estate is arguably the clearest evidence yet that longevity has outgrown its identity as purely a scientific or medical pursuit — it's becoming infrastructure, embedded directly into where people live, and something investors can own outright rather than just fund indirectly.
For investors, that opens up an entry point that early-stage biotech simply can't offer. A longevity drug is a binary, illiquid, years-long bet on a single outcome. A ReHealth Estate property, by contrast, is a tangible asset generating recurring income, occupied by a resident who has already self-selected as someone who prioritizes their long-term health — the identical underlying trend, just expressed through cash flow instead of a single clinical trial result.
Still, real estate's arrival in this space cuts both ways for the broader movement. It brings scale, mainstream visibility, and — thanks to Abu Dhabi's new licensing framework — the first real steps toward formal regulation, all of which lend legitimacy. But it also invites the same dilution that follows every fast-growing category: developments that borrow the vocabulary of longevity without funding any of the substance behind it, which risks undercutting the credibility that the actual science has spent years building. That's precisely why the same rigor a serious investor applies to evaluating a new drug — evidence over hype, operator track record over brand name — now needs to apply to a building as well. Done right, ReHealth Estate might be one of the most tangible ways yet to actually back longer, healthier lives. Done carelessly, it's just an expensive lobby with impressive lighting.
Written by: Dana Marduk